Literature DB >> 20055437

Biochemical analysis of phenotypic diversity associated with mutations in codon 244 of the retinal degeneration slow gene.

Shannon M Conley1, Heidi M Stricker, Muna I Naash.   

Abstract

Mutations in the protein product of the retinal degeneration slow (RDS) gene cause both rod-dominant retinitis pigmentosa and different forms of cone-dominant macular dystrophies. In particular, mutations in codon 244 can cause either of these types of disease. In this study, we examine the biochemical effects of N244H and N244K in an effort to understand the mechanism underlying rod- and cone-dominant defects, respectively. COS-1 cells were cotransfected with either wild-type (WT) RDS or RDS containing an N244H or N244K mutation along with its binding partner, ROM-1 (rod outer segment membrane protein 1). Cell extracts were analyzed for mutant protein stability by Western blot, and localization was examined by immunocytochemistry. Interactions between transfected proteins were assessed by reciprocal co-immunoprecipitation, and nonreducing velocity sedimentation was used to identify the pattern of RDS complex assembly. Interactions were confirmed using GST fusion constructs of WT and mutant RDS in GST pull-down assays from WT mouse retinal extract. In COS-1 cells, recombinant N244H RDS had a weakened ability to assemble into higher-order complexes but retained the ability to co-immunoprecipitate with ROM-1 as well as localize properly throughout the cells. In contrast, recombinant N244K protein did not associate with ROM-1, showed signs of protein aggregation, and colocalized with an ER marker. These experiments support the hypothesis that RDS mutations that interrupt higher-order oligomer formation but still interact with ROM-1 and fold properly in membranes may cause dominant, gain-of-function disease phenotypes while mutations that cause RDS misfolding (and thus incorrect trafficking and assembly) may be associated with a loss-of-function haploinsufficiency phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20055437      PMCID: PMC2937569          DOI: 10.1021/bi901622w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Expression and characterization of peripherin/rds-rom-1 complexes and mutants implicated in retinal degenerative diseases.

Authors:  A F Goldberg; R S Molday
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Asn244His mutation of the peripherin/RDS gene causing autosomal dominant cone-rod degeneration.

Authors:  M Nakazawa; E Kikawa; Y Chida; M Tamai
Journal:  Hum Mol Genet       Date:  1994-07       Impact factor: 6.150

3.  Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins.

Authors:  J V Frangioni; B G Neel
Journal:  Anal Biochem       Date:  1993-04       Impact factor: 3.365

4.  The R172W mutation in peripherin/rds causes a cone-rod dystrophy in transgenic mice.

Authors:  Xi-Qin Ding; May Nour; Linda M Ritter; Andrew F X Goldberg; Steven J Fliesler; Muna I Naash
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

5.  Differential requirements for retinal degeneration slow intermolecular disulfide-linked oligomerization in rods versus cones.

Authors:  Dibyendu Chakraborty; Xi-Qin Ding; Shannon M Conley; Steven J Fliesler; Muna I Naash
Journal:  Hum Mol Genet       Date:  2008-12-02       Impact factor: 6.150

6.  Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression.

Authors:  May Nour; Xi-Qin Ding; Heidi Stricker; Steven J Fliesler; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-08       Impact factor: 4.799

7.  Ocular findings in patients with autosomal dominant retinitis pigmentosa and transversion mutation in codon 244 (Asn244Lys) of the peripherin/RDS gene.

Authors:  M Nakazawa; E Kikawa; K Kamio; Y Chida; T Shiono; M Tamai
Journal:  Arch Ophthalmol       Date:  1994-12

8.  Heterologous expression of photoreceptor peripherin/rds and Rom-1 in COS-1 cells: assembly, interactions, and localization of multisubunit complexes.

Authors:  A F Goldberg; O L Moritz; R S Molday
Journal:  Biochemistry       Date:  1995-10-31       Impact factor: 3.162

9.  The retinal degeneration slow (rds) gene product is a photoreceptor disc membrane-associated glycoprotein.

Authors:  G H Travis; J G Sutcliffe; D Bok
Journal:  Neuron       Date:  1991-01       Impact factor: 17.173

10.  Association of a photoreceptor-specific tetraspanin protein, ROM-1, with triton X-100-resistant membrane rafts from rod outer segment disk membranes.

Authors:  Kathleen Boesze-Battaglia; Janice Dispoto; Mary Anne Kahoe
Journal:  J Biol Chem       Date:  2002-08-23       Impact factor: 5.157

View more
  18 in total

1.  Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90).

Authors:  Lawrence C S Tam; Anna-Sophia Kiang; Matthew Campbell; James Keaney; G Jane Farrar; Marian M Humphries; Paul F Kenna; Pete Humphries
Journal:  Hum Mol Genet       Date:  2010-09-02       Impact factor: 6.150

2.  Retinal Degeneration Slow (RDS) Glycosylation Plays a Role in Cone Function and in the Regulation of RDS·ROM-1 Protein Complex Formation.

Authors:  Michael W Stuck; Shannon M Conley; Muna I Naash
Journal:  J Biol Chem       Date:  2015-09-29       Impact factor: 5.157

3.  Differences in RDS trafficking, assembly and function in cones versus rods: insights from studies of C150S-RDS.

Authors:  Dibyendu Chakraborty; Shannon M Conley; Michael W Stuck; Muna I Naash
Journal:  Hum Mol Genet       Date:  2010-09-21       Impact factor: 6.150

4.  Rom1 converts Y141C-Prph2-associated pattern dystrophy to retinitis pigmentosa.

Authors:  Shannon M Conley; Michael W Stuck; Jamie N Watson; Muna I Naash
Journal:  Hum Mol Genet       Date:  2017-02-01       Impact factor: 6.150

Review 5.  A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: a better understanding of the pathophysiology using the newest genetic strategies.

Authors:  F S Sorrentino; C E Gallenga; C Bonifazzi; P Perri
Journal:  Eye (Lond)       Date:  2016-08-26       Impact factor: 3.775

6.  Insights into the mechanisms of macular degeneration associated with the R172W mutation in RDS.

Authors:  Shannon M Conley; Michael W Stuck; Justin L Burnett; Dibyendu Chakraborty; Seifollah Azadi; Steven J Fliesler; Muna I Naash
Journal:  Hum Mol Genet       Date:  2014-01-25       Impact factor: 6.150

Review 7.  PRPH2/RDS and ROM-1: Historical context, current views and future considerations.

Authors:  Michael W Stuck; Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2016-01-08       Impact factor: 21.198

8.  The Y141C knockin mutation in RDS leads to complex phenotypes in the mouse.

Authors:  Michael W Stuck; Shannon M Conley; Muna I Naash
Journal:  Hum Mol Genet       Date:  2014-07-07       Impact factor: 6.150

Review 9.  Gene therapy for PRPH2-associated ocular disease: challenges and prospects.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-28       Impact factor: 6.915

10.  Structural characterization of the second intra-discal loop of the photoreceptor tetraspanin RDS.

Authors:  Dibyendu Chakraborty; Karla K Rodgers; Shannon M Conley; Muna I Naash
Journal:  FEBS J       Date:  2012-11-22       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.